A family with two children diagnosed with aspartylglucosaminuria-case report and literature review

OBJECTIVE: The authors sought to investigate the clinical features and characteristics of genetic mutation in patients with aspartylglucosaminuria

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 52(2014), 6 vom: 04. Juni, Seite 455-9
1. Verfasser: Liu, Yujie (VerfasserIn)
Weitere Verfasser: Zou, Liping, Meng, Yan, Zhang, Ying, Shi, Xiuyu, Ju, Jun, Yang, Guang, Hu, Linyan, Chen, Xiaoqiao
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Case Reports English Abstract Journal Article Review Biomarkers Aspartylglucosylaminase EC 3.5.1.26
LEADER 01000caa a22002652c 4500
001 NLM241605253
003 DE-627
005 20250217111904.0
007 tu
008 231224s2014 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0805.xml 
035 |a (DE-627)NLM241605253 
035 |a (NLM)25190167 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Liu, Yujie  |e verfasserin  |4 aut 
245 1 2 |a A family with two children diagnosed with aspartylglucosaminuria-case report and literature review 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 13.01.2015 
500 |a Date Revised 07.06.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: The authors sought to investigate the clinical features and characteristics of genetic mutation in patients with aspartylglucosaminuria 
520 |a METHOD: Clinical data of two pediatric siblings in a family were analyzed retrospectively and relative literature was reviewed in order to study the clinical features, imaging and enzymatic characteristics and genetic mutations 
520 |a RESULT: Case 1, the proband, male, he was hospitalized at 20 months of age because of fever and hepatosplenomegaly for nine days. This child was of moderate nutritional status and normal development. Blood tests showed hemoglobin 78.0 g/L, RBC3.18 × 10¹²/L, WBC 4.06 × 10⁹/L, neutrophils 0.236, lymphocytes 0.631, platelets 34 × 10⁹/L, C-reactive protein 17 mg/L. Blood biochemistry showed alanine aminotransferase 67.1 U/L, aspartate aminotransferase 74.1 U/L, serum albumin 32.8 g/L, direct bilirubin 10.5 µmol/L, lactate dehydrogenase 301.7 U/L. Bone marrow cytology showed reactive morphological changes in bone marrow cells. Atypical lymphocytes could be seen in both peripheral blood and bone marrow smears. Cranial MRI showed poor myelination. Aspartylglucosaminidase activity in peripheral leucocytes of the proband 5.7 nmol/(g × min) vs. normal control>26.6 nmol/(g × min). On his AGA gene and that of his parents, a heterozygous mutation site located in exon 3, c.392C>T (p.S131L), was identified as a novel mutation inherited from his father. The mutation from his mother has not been detected. The proband was not responsive to the anti-infectious medication, nutritional intervention and symptomatic treatment.He died one month after diagnosis.His elder brother, Case 2, showed fever, recurrent respiratory tract infection and progressive psychomotor regression with hepatosplenomegaly from the age of four years. Cranial MRI revealed extensive symmetrical leukodystrophy in bilateral cerebra, cerebellum and brainstem.He died at the age of six years.Related literature was summarized, and no Chinese AGU cases had been reported; 221 foreign cases were collected. The clinical and imaging characteristics were summarized. Delay in language development was one of the clinical symptoms that the majority of parents of AGU children first noted 
520 |a CONCLUSION: Patients with aspartylglucosaminuria lack of specific symptoms.For children with unexplained delayed speech and progressive mental retardation, the possibility of AGU should be considered, and efforts be made for enzymatic and genetic diagnosis. c.392C> T (p.S131L) was identified as a novel mutation of AGA gene 
650 4 |a Case Reports 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 4 |a Review 
650 7 |a Biomarkers  |2 NLM 
650 7 |a Aspartylglucosylaminase  |2 NLM 
650 7 |a EC 3.5.1.26  |2 NLM 
700 1 |a Zou, Liping  |e verfasserin  |4 aut 
700 1 |a Meng, Yan  |e verfasserin  |4 aut 
700 1 |a Zhang, Ying  |e verfasserin  |4 aut 
700 1 |a Shi, Xiuyu  |e verfasserin  |4 aut 
700 1 |a Ju, Jun  |e verfasserin  |4 aut 
700 1 |a Yang, Guang  |e verfasserin  |4 aut 
700 1 |a Hu, Linyan  |e verfasserin  |4 aut 
700 1 |a Chen, Xiaoqiao  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 52(2014), 6 vom: 04. Juni, Seite 455-9  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnas 
773 1 8 |g volume:52  |g year:2014  |g number:6  |g day:04  |g month:06  |g pages:455-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
912 |a GBV_ILN_1121 
951 |a AR 
952 |d 52  |j 2014  |e 6  |b 04  |c 06  |h 455-9